Bulgaria
3

Dispute resolution

Stankov, Todorov, Hinkov & Spasov

Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :

Schoenherr logo
Schoenherr
Kinstellar logo
Kinstellar
CasePro logo
CasePro
The ‘excellent team of professionals’ at Stankov, Todorov, Hinkov & Spasov have extensive experience advising public entities, namely state departments and local municipalities, in a broad array of administrative disputes across the agriculture, pharma, energy and construction sectors. Mihail Stankov and Hristo Hinkov are joint practice heads, with the former being well versed in bankruptcy and insolvency proceedings, and the latter focusing M&A, restructuring and project finance mandates and the related contentious matters. The team grew in April 2024, when Petya Stankova-Ilieva joined from Georgiev, Todorov & Co.
L’éditorial du Legal 500

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • ‘This practice stands out due to its depth of experience, and a tailored approach to client needs such as its specialised focus in corporate law and labour law. What truly differentiates it is the firm’s emphasis on the team's ability to handle complex cases with precision and deliver high-quality, strategic legal counsel ensures clients receive not only legal advice but also comprehensive business solutions.’

  • ‘I’ve particularly valued their attention to detail. Their proactive communication and ability to anticipate client needs have been critical in building trust and ensuring positive outcomes. Specifically, I’ve been impressed by Simeon Hinkov.’

Clients clés

  • Oxford Integrated Logistics Jsc.
  • State Agriculture Fund

Points forts

  • Advised State Fund Agriculture in numerous court proceedings against unlawful transfers of ownership of debtors`real estate.
  • Advised Besta Med Ltd. in court proceedings against the National Council on Prices and Reimbursement of Medicinal Products in relation to unlawful price formation of parallel imported medicinal products.